Tag:
Achillion
Latest Headlines
Latest Headlines
Achillion burnishes buyout prospects, snags fast track for hep C drug
Achillion CEO Michael Kishbauch hasn't been the least bit shy about touting the company's buyout prospects. Quick to boast about the biotech's promising hepatitis C drugs, he's been raising hopes and stirring buyout buzz with every appearance.
JPM kicks off with fevered focus on the next big biotech deal
The news of the Bristol-Myers/Inhibitex deal couldn't have been better timed. With the biotech world converging on San Francisco today for the annual JP Morgan confab, there's nothing like a
